You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD28 and IL-6 biologic blockade

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

Not yet recruiting
  • Crohn Disease
  • TNFa Antagonist - Infliximab
  • +5 more
  • Calgary, Alberta, Canada
    University of Calgary
Jun 22, 2023

Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

Completed
  • Interleukin-6 Inhibition
  • +2 more
  • Tocilizumab Injectable Product
  • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
  • Copenhagen Ø, Denmark
    Center For Physical Activity (CFAS)
Aug 19, 2022

Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

Not yet recruiting
  • Non Hodgkin's Lymphoma
  • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
  • +2 more
  • Beijing, China
  • +2 more
Aug 23, 2023

IL-13 Blockade and Airway Autoimmunity in Asthma

Not yet recruiting
  • Airway Auto Immunity in Asthma
    • (no location specified)
    Sep 30, 2022

    Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)

    Not yet recruiting
    • Kidney Transplantation
    • Renal Transplant Recipients
    • Lulizumab
    • +5 more
    • Atlanta, Georgia
      Emory University Hospital
    Sep 22, 2021

    COVID Trial in United States (SARILUMAB)

    Completed
    Has Results
    • COVID
    • SARILUMAB
    • West Haven, Connecticut
    • +4 more
    Sep 14, 2022

    Lung Cancer Squamous Cell Trial in Stuttgart, Tuebingen (CC-1 and Toczilizumab)

    Recruiting
    • Lung Cancer Squamous Cell
    • CC-1 and Toczilizumab
    • Stuttgart, BW, Germany
    • +1 more
    Feb 2, 2022

    Psoriasis of Scalp Trial in San Francisco (Guselkumab)

    Recruiting
    • Psoriasis of Scalp
    • San Francisco, California
      University of California San Francisco
    May 4, 2023

    Neuromuscular Blockade, Innate Inflammatory Response, Quality of Life Trial in Nijmegen (Rocuronium Bromide)

    Recruiting
    • Neuromuscular Blockade
    • +3 more
    • Rocuronium Bromide
    • Nijmegen, Netherlands
      Radboudumc
    Jan 8, 2023

    Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston

    Recruiting
    • Refractory B-Cell Non-Hodgkin Lymphoma
    • +4 more
    • CD19.CAR-aNKT cells
    • +2 more
    • Houston, Texas
    • +1 more
    Aug 19, 2022

    Knee Osteoarthritis Trial in Paris (PPV-06 10 µg, PPV-06 50 µg, Placebo)

    Recruiting
    • Knee Osteoarthritis
    • PPV-06 10 μg
    • +2 more
    • Paris, France
      Cic Cochin
    Apr 25, 2022

    Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

    Not yet recruiting
    • Non-muscular Invasive Bladder Cancer
    • BCG for therapeutic use
    • Changsha, China
      Hunan Cancer Hospital
    Oct 20, 2023

    Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

    Not yet recruiting
    • Advanced Solid Tumors
    • Recombinant human IL-21 oncolytic vaccinia virus injection
    • Hangzhou, Zhejiang, China
    • +1 more
    Jun 21, 2023

    Psoriasis Trial in New York (Risankizumab-Rzaa, Punch biopsies of the skin at baseline visit, Punch biopsies of the skin at week

    Recruiting
    • Psoriasis
    • New York, New York
      The Rockefeller Univesity
    Jun 9, 2022

    Circulating Cluster of Differentiation 4 Positive 28 Null T

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
      • (no location specified)
      Jan 31, 2023

      Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

      Not yet recruiting
      • Unmethylated Glioblastoma
      • Personalized Neoantigen DNA vaccine
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Feb 14, 2023

      Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

      Not yet recruiting
      • Esophagus Cancer
      • +4 more
      • Intravenous injection of P-IL-2
      • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
      • (no location specified)
      Apr 24, 2023

      Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

      Active, not recruiting
      • Breast Cancer
      • +2 more
      • Brasschaat, Belgium
      • +53 more
      Nov 29, 2022

      Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

      Not yet recruiting
      • Breast Cancer
      • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
      • Ottawa, Ontario, Canada
      • +1 more
      Jul 22, 2023

      Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

      Recruiting
      • Adamantinomatous Craniopharyngioma
      • Recurrent Adamantinomatous Craniopharyngioma
      • Aurora, Colorado
      • +17 more
      Jan 8, 2023

      Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

      Recruiting
      • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
      • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
      • ELISA and colorimeter
      • Assiut, Egypt
        Biochemistry department,Faculty of medicine
      Oct 10, 2023

      Sepsis, Septic Shock Trial in Kayseri (Mesenchymal stem cells)

      Completed
      • Sepsis
      • Septic Shock
      • Mesenchymal stem cells
      • Kayseri, Turkey
        Erciyes University
      Mar 11, 2022

      Metastatic Uveal Melanoma in the Liver Trial in United States (SD-101, Nivolumab, Ipilimumab)

      Recruiting
      • Metastatic Uveal Melanoma in the Liver
      • Los Angeles, California
      • +9 more
      Jan 27, 2023

      Psoriasis Trial (Secukinumab 300 mg, Placebo)

      Withdrawn
      • Psoriasis
      • Secukinumab 300 mg
      • Placebo
      • (no location specified)
      Jan 30, 2022

      Metastatic Breast Cancer Trial in Dallas (Anakinra plus Standard of Care)

      Completed
      • Metastatic Breast Cancer
      • Anakinra plus Standard of Care
      • Dallas, Texas
        Baylor University Medical Center
      Oct 7, 2021